{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:01:28Z","timestamp":1790326888484,"version":"4.1.0"},"reference-count":240,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.coms.2026.08.002","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:35:18Z","timestamp":1790321718000},"page":"483-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biological and Molecular Biomarkers in Oral Potentially Malignant Disorders and Oral Cavity Squamous Cell Carcinoma\u2014Innovation and Insights"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5965-6181","authenticated-orcid":false,"given":"Prokopios P.","family":"Argyris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9666-7608","authenticated-orcid":false,"given":"Mark W.","family":"Lingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coms.2026.08.002_bib1","series-title":"WHO classification of tumours editorial board. Head and neck tumours [internet]","year":"2023"},{"key":"10.1016\/j.coms.2026.08.002_bib2","unstructured":"Ferlay J, Ervik M, Lam F, et al, Global cancer observatory: cancer today (version 1.0), 2024, International Agency for Research on Cancer, Available at: https:\/\/gco.iarc.who.int\/today (Accessed 25 February 2025)."},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib3","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/ccd.ccd_1_20","article-title":"Distribution pattern and its correlation for oral cancer rate and human development rank for countries: an ecological approach","volume":"12","author":"Kuruvilla","year":"2021","journal-title":"Contemp Clin Dent"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hed.24589","article-title":"Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study","volume":"39","author":"Ng","year":"2017","journal-title":"Head Neck"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib6","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s00784-025-06213-8","article-title":"Unique clinical features and prognostic risk factors of oral squamous cell carcinoma in patients under 30 years old","volume":"29","author":"Cheng","year":"2025","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.coms.2026.08.002_bib7","series-title":"Oral and maxillofacial pathology","author":"Neville","year":"2024"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.seminoncol.2004.09.011","article-title":"Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity","volume":"31","author":"Gillison","year":"2004","journal-title":"Semin Oncol"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/(SICI)1097-0347(199805)20:3<250::AID-HED11>3.0.CO;2-O","article-title":"Human papillomavirus and head and neck cancer: epidemiology and molecular biology","volume":"20","author":"McKaig","year":"1998","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib10","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.hoc.2008.08.007","article-title":"Molecular biology of head and neck cancer: risks and pathways","volume":"22","author":"Stadler","year":"2008","journal-title":"Hematol Oncol Clin N Am"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib11","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00784-019-02958-1","article-title":"The synergistic effect of tobacco and alcohol consumption on oral squamous cell carcinoma: a systematic review and meta-analysis","volume":"23","author":"Mello","year":"2019","journal-title":"Clin Oral Investig"},{"key":"10.1016\/j.coms.2026.08.002_bib12","doi-asserted-by":"crossref","DOI":"10.2196\/51936","article-title":"Oral cancer incidence among adult males with current or former use of cigarettes or smokeless tobacco: population-based study","volume":"10","author":"Noggle","year":"2024","journal-title":"JMIR Cancer"},{"issue":"11","key":"10.1016\/j.coms.2026.08.002_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113385","article-title":"Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in south Asia and the Pacific","volume":"9","author":"Gupta","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2012.07.002","article-title":"Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas","volume":"49","author":"Lingen","year":"2013","journal-title":"Oral Oncol"},{"issue":"29","key":"10.1016\/j.coms.2026.08.002_bib15","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma","volume":"33","author":"Gillison","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coms.2026.08.002_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.oraloncology.2016.03.003","article-title":"Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus","volume":"56","author":"Zafereo","year":"2016","journal-title":"Oral Oncol"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ijc.33514","article-title":"The unveiled reality of human papillomavirus as risk factor for oral cavity squamous cell carcinoma","volume":"149","author":"Nauta","year":"2021","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1368-8375(00)00055-5","article-title":"A review of inherited cancer syndromes and their relevance to oral squamous cell carcinoma","volume":"37","author":"Prime","year":"2001","journal-title":"Oral Oncol"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.oraloncology.2013.11.001","article-title":"Oral squamous cell carcinoma in patients twenty years of age or younger--review and analysis of 186 reported cases","volume":"50","author":"Bodner","year":"2014","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib20","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1001\/archotol.129.1.106","article-title":"High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia","volume":"129","author":"Kutler","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"26","key":"10.1016\/j.coms.2026.08.002_bib21","doi-asserted-by":"crossref","first-page":"6549","DOI":"10.1182\/blood-2008-12-192880","article-title":"Cancer in dyskeratosis congenita","volume":"113","author":"Alter","year":"2009","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.5005\/jp-journals-10024-1880","article-title":"Oral cancer-related inherited cancer syndromes: a comprehensive review","volume":"17","author":"Sarode","year":"2016","journal-title":"J Contemp Dent Pract"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib25","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.21873\/invivo.11020","article-title":"Prevalence of EGFR tyrosine kinase domain mutations in head and neck squamous cell carcinoma: Cohort study and systematic review","volume":"31","author":"Perisanidis","year":"2017","journal-title":"In Vivo"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib27","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s11864-023-01080-5","article-title":"Current state and future directions of EGFR-directed therapy in head and neck cancer","volume":"24","author":"Tathineni","year":"2023","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2013.03.003","article-title":"HER2 status for prognosis and prediction of treatment efficacy in adenocarcinomas: a review","volume":"88","author":"Thibault","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.coms.2026.08.002_bib29","first-page":"1","article-title":"Emerging monoclonal antibody therapy for head and neck squamous cell carcinoma","author":"Proulx-Rocray","year":"2024","journal-title":"Expert Opin Emerg Drugs"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib30","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3390\/curroncol31040150","article-title":"KRAS: biology, inhibition, and mechanisms of inhibitor resistance","volume":"31","author":"Ash","year":"2024","journal-title":"Curr Oncol"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41591-024-02903-0","article-title":"Targeting KRAS in cancer","volume":"30","author":"Singhal","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.coms.2026.08.002_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116194","article-title":"MYC the oncogene from hell: novel opportunities for cancer therapy","volume":"267","author":"Papadimitropoulou","year":"2024","journal-title":"Eur J Med Chem"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib33","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41418-022-00988-z","article-title":"Cell cycle regulation: p53-p21-RB signaling","volume":"29","author":"Engeland","year":"2022","journal-title":"Cell Death Differ"},{"issue":"12","key":"10.1016\/j.coms.2026.08.002_bib34","article-title":"Expanding roles of the E2F-RB-p53 pathway in tumor suppression","volume":"12","author":"Zhou","year":"2023","journal-title":"Biology (Basel)"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41568-018-0008-5","article-title":"Non-canonical functions of the RB protein in cancer","volume":"18","author":"Dick","year":"2018","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12964-023-01365-0","article-title":"Molecular pathways in the development of HPV-Induced oropharyngeal cancer","volume":"21","author":"Ullah","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.coms.2026.08.002_bib37","article-title":"Decoding p53 tumor suppression: a crosstalk between genomic stability and epigenetic control?","author":"Janic","year":"2024","journal-title":"Cell Death Differ"},{"issue":"15","key":"10.1016\/j.coms.2026.08.002_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153664","article-title":"Li-Fraumeni syndrome: mutation of TP53 is a biomarker of hereditary predisposition to tumor: new insights and advances in the treatment","volume":"14","author":"Rocca","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.coms.2026.08.002_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2023.102522","article-title":"Germline TP53 pathogenic variants and breast cancer: a narrative review","volume":"114","author":"Blondeaux","year":"2023","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29191","article-title":"Human papillomaviruses: knowns, mysteries, and unchartered territories","volume":"95","author":"Gelbard","year":"2023","journal-title":"J Med Virol"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib41","doi-asserted-by":"crossref","first-page":"478","DOI":"10.33594\/000000671","article-title":"Mechanisms of senescence in cancer: positive and negative aspects of cancer cells senescence","volume":"57","author":"Zaczek","year":"2023","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.coms.2026.08.002_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216459","article-title":"Telomerase and hallmarks of cancer: an intricate interplay governing cancer cell evolution","volume":"578","author":"Kumar","year":"2023","journal-title":"Cancer Lett"},{"key":"10.1016\/j.coms.2026.08.002_bib43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/bs.ircmb.2024.01.006","article-title":"Mitochondria driven innate immune signaling and inflammation in cancer growth, immune evasion, and therapeutic resistance","volume":"386","author":"Pandey","year":"2024","journal-title":"Int Rev Cell Mol Biol"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25063142","article-title":"Targeting the warburg effect in cancer: where do we stand?","volume":"25","author":"Barba","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib45","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.apsb.2023.12.003","article-title":"Targeting the warburg effect: a revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer","volume":"14","author":"Liao","year":"2024","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"10.1016\/j.coms.2026.08.002_bib46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc.2017.51","article-title":"Microenvironmental regulation of tumour angiogenesis","volume":"17","author":"De Palma","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16101794","article-title":"Angiogenesis still plays a crucial role in human melanoma progression","volume":"16","author":"Cazzato","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib48","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41392-023-01460-1","article-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"7347","key":"10.1016\/j.coms.2026.08.002_bib49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.coms.2026.08.002_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114806","article-title":"New advances in the research of clinical treatment and novel anticancer agents in tumor angiogenesis","volume":"163","author":"Li","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010084","article-title":"Tumor angiogenesis and anti-angiogenic strategies for cancer treatment","volume":"9","author":"Teleanu","year":"2019","journal-title":"J Clin Med"},{"issue":"14","key":"10.1016\/j.coms.2026.08.002_bib52","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-10-1040","article-title":"AACR centennial series: the biology of cancer metastasis: historical perspective","volume":"70","author":"Talmadge","year":"2010","journal-title":"Cancer Res"},{"issue":"12","key":"10.1016\/j.coms.2026.08.002_bib53","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/nrc3628","article-title":"Crossing the endothelial barrier during metastasis","volume":"13","author":"Reymond","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12020418","article-title":"Epithelial-mesenchymal transition: a fundamental cellular and microenvironmental process in benign and malignant prostate pathologies","volume":"12","author":"Goncharov","year":"2024","journal-title":"Biomedicines"},{"issue":"9","key":"10.1016\/j.coms.2026.08.002_bib55","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41576-023-00601-0","article-title":"The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation","volume":"24","author":"Haerinck","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib56","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nrc2622","article-title":"Metastasis: from dissemination to organ-specific colonization","volume":"9","author":"Nguyen","year":"2009","journal-title":"Nat Rev Cancer"},{"issue":"13","key":"10.1016\/j.coms.2026.08.002_bib57","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1158\/0008-5472.CAN-13-0356","article-title":"The dormancy dilemma: quiescence versus balanced proliferation","volume":"73","author":"Wells","year":"2013","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib58","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s12105-022-01451-8","article-title":"Metastatic tumors to the oral soft tissues and jawbones: a retrospective analysis of 40 cases and review of the literature","volume":"16","author":"Ho","year":"2022","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.coms.2026.08.002_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2025.107210","article-title":"Multistate oral carcinogenesis-A prospective cohort study and a parallel case-control study in Taiwan","volume":"162","author":"Wang","year":"2025","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib60","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12105-007-0014-5","article-title":"Update on oral epithelial dysplasia and progression to cancer","volume":"1","author":"Speight","year":"2007","journal-title":"Head Neck Pathol"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib61","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hed.26006","article-title":"Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype","volume":"42","author":"Iocca","year":"2020","journal-title":"Head Neck"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib62","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/hed.25579","article-title":"Impact of varying anatomic sites on advanced stage and survival of oral cancer: 9-year prospective cohort of 27 717 cases","volume":"41","author":"Su","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.coms.2026.08.002_bib63","series-title":"Cancer facts & figures 2025","year":"2025"},{"issue":"11","key":"10.1016\/j.coms.2026.08.002_bib64","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1093\/annonc\/mdx486","article-title":"Alcohol and cigarette consumption predict mortality in patients with head and neck cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium","volume":"28","author":"Giraldi","year":"2017","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib65","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.amjoto.2012.01.009","article-title":"Prognostic features, human papillomavirus status, and epidermal growth factor receptor expression in oral squamous cell carcinoma in young adults","volume":"33","author":"Thomas","year":"2012","journal-title":"Am J Otolaryngol"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib66","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.oraloncology.2010.01.008","article-title":"Surgical outcomes and prognostic factors of oral cancer associated with betel quid chewing and tobacco smoking in Taiwan","volume":"46","author":"Liu","year":"2010","journal-title":"Oral Oncol"},{"key":"10.1016\/j.coms.2026.08.002_bib67","doi-asserted-by":"crossref","DOI":"10.1177\/2057178X17738912","article-title":"Clinico-pathological prognosticators in oral squamous cell carcinoma: an update","volume":"2","author":"Majumdar","year":"2017","journal-title":"Translational Research in Oral Oncology"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.jormas.2024.102149","article-title":"Prognostic implications across histological subtypes of head and neck squamous cell carcinoma: an update","volume":"126","author":"Goncalves","year":"2024","journal-title":"J Stomatol Oral Maxillofac Surg"},{"key":"10.1016\/j.coms.2026.08.002_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.oooo.2024.04.059","article-title":"SATB2 expression in oral sarcomatoid (spindle cell) squamous cell carcinoma: clinicopathologic and immunophenotypic characterization of 10 cases","author":"Speakman","year":"2024","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib70","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.joms.2013.04.004","article-title":"Comparison between p16 INK4A immunohistochemistry and human papillomavirus polymerase chain reaction assay in oral papillary squamous cell carcinoma","volume":"71","author":"Argyris","year":"2013","journal-title":"J Oral Maxillofac Surg"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/cncr.26229","article-title":"Early stage squamous cell cancer of the oral tongue--clinicopathologic features affecting outcome","volume":"118","author":"Ganly","year":"2012","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.coms.2026.08.002_bib72","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1001\/jamaoto.2014.1548","article-title":"Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion: an international multicenter retrospective study","volume":"140","author":"Neck","year":"2014","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib73","first-page":"122","article-title":"Head and neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual","volume":"67","author":"Lydiatt","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib74","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.bjoms.2009.12.013","article-title":"Oral and oropharyngeal cancer in the West of scotland-long-term outcome data of a prospective audit 1999-2001","volume":"49","author":"McMahon","year":"2011","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib75","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12105-020-01221-4","article-title":"Histopathological definitions of extranodal extension: a systematic review","volume":"15","author":"Abdel-Halim","year":"2021","journal-title":"Head Neck Pathol"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib76","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/hed.21244","article-title":"Extracapsular spread in oral squamous cell carcinoma","volume":"32","author":"Shaw","year":"2010","journal-title":"Head Neck"},{"issue":"Suppl 1","key":"10.1016\/j.coms.2026.08.002_bib77","first-page":"E1192","article-title":"Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma","volume":"38 Suppl 1","author":"Wreesmann","year":"2016","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.coms.2026.08.002_bib78","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.oraloncology.2006.09.010","article-title":"A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with post-operative radiotherapy","volume":"43","author":"Brown","year":"2007","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib79","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jcms.2024.11.016","article-title":"Lymph node ratio (LNR) and lymph node yield (LNY) in head and neck cancer: a systematic review and meta-analysis","volume":"53","author":"Iocca","year":"2025","journal-title":"J Craniomaxillofac Surg"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/ams.ams_82_23","article-title":"Prognostic significance of lymph node ratio in predicting the outcome of oral squamous cell carcinoma - a retrospective study","volume":"14","author":"Sansgiri","year":"2024","journal-title":"Ann Maxillofac Surg"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib81","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.pas.0000149687.90710.21","article-title":"Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival","volume":"29","author":"Brandwein-Gensler","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.coms.2026.08.002_bib82","article-title":"Tumor budding as an independent prognostic histopathological marker in oral squamous cell carcinoma - an Indian tertiary care center experience","author":"Narayanan","year":"2025","journal-title":"Turk Patoloji Derg"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib83","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1007\/s12070-024-04661-4","article-title":"Prognostic role of tumor budding and worst pattern of invasion in lymph node metastasis and disease-free survival in oral squamous cell cancer patients: result from central India\u2019s regional cancer centre","volume":"76","author":"Badanale","year":"2024","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib84","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/hed.23380","article-title":"Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer","volume":"36","author":"Almangush","year":"2014","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib85","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s00405-012-2317-8","article-title":"Surgical margins in head and neck squamous cell carcinoma: what is \u2018close\u2019?","volume":"270","author":"Alicandri-Ciufelli","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.coms.2026.08.002_bib86","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.oraloncology.2017.10.013","article-title":"Improving margin revision: characterization of tumor bed margins in early oral tongue cancer","volume":"75","author":"Prabhu","year":"2017","journal-title":"Oral Oncol"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib87","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0714.2002.310103.x","article-title":"The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients","volume":"31","author":"Weijers","year":"2002","journal-title":"J Oral Pathol Med"},{"issue":"12","key":"10.1016\/j.coms.2026.08.002_bib88","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1001\/jamaoto.2015.1351","article-title":"Early oral tongue squamous cell carcinoma: sampling of margins from tumor bed and worse local control","volume":"141","author":"Maxwell","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"18","key":"10.1016\/j.coms.2026.08.002_bib89","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1002\/cncr.32199","article-title":"Early squamous cell carcinoma of the oral tongue with histologically benign lymph nodes: a model predicting local control and vetting of the eighth edition of the American Joint Committee on cancer pathologic T stage","volume":"125","author":"Sridharan","year":"2019","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib90","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0194599819839006","article-title":"Does clearance of positive margins improve local control in oral cavity cancer? A meta-analysis","volume":"161","author":"Bulbul","year":"2019","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib91","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molonc.2012.01.010","article-title":"Cancer biomarkers","volume":"6","author":"Henry","year":"2012","journal-title":"Mol Oncol"},{"issue":"9804","key":"10.1016\/j.coms.2026.08.002_bib92","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby","year":"2011","journal-title":"Lancet"},{"issue":"9742","key":"10.1016\/j.coms.2026.08.002_bib93","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.coms.2026.08.002_bib94","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1200\/JCO.2009.26.4481","article-title":"American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors","volume":"28","author":"Gilligan","year":"2010","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib95","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1200\/JOP.777010","article-title":"ASCO clinical practice guideline on uses of serum tumor markers in adult males with germ cell tumors","volume":"6","author":"Gilligan","year":"2010","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.coms.2026.08.002_bib96","article-title":"APOBEC3B high expression status is associated with aggressive phenotype in Japanese breast cancers","author":"Tsuboi","year":"2015","journal-title":"Breast Cancer"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib97","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12672-014-0196-8","article-title":"Elevated APOBEC3B correlates with poor outcomes for estrogen-receptor-positive breast cancers","volume":"5","author":"Sieuwerts","year":"2014","journal-title":"Hormones & cancer"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib98","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1601737","article-title":"The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer","volume":"2","author":"Law","year":"2016","journal-title":"Sci Adv"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib99","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41467-017-00493-9","article-title":"APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism","volume":"8","author":"Chen","year":"2017","journal-title":"Nat Commun"},{"issue":"13","key":"10.1016\/j.coms.2026.08.002_bib100","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1158\/1078-0432.CCR-19-2786","article-title":"The DNA cytosine deaminase APOBEC3B is a molecular determinant of platinum responsiveness in clear cell ovarian cancer","volume":"26","author":"Serebrenik","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib101","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41379-020-0617-x","article-title":"Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-Negative oral epithelial dysplasias and head and neck cancers","volume":"34","author":"Argyris","year":"2021","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.coms.2026.08.002_bib102","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011939","article-title":"Nuclear S100A7 is associated with poor prognosis in head and neck cancer","volume":"5","author":"Tripathi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.coms.2026.08.002_bib103","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.oraloncology.2017.07.003","article-title":"Prognostic biomarkers in oral squamous cell carcinoma: a systematic review","volume":"72","author":"Rivera","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.coms.2026.08.002_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100285","article-title":"The role of molecular biomarkers in the diagnosis, prognosis, and treatment stratification of oral squamous cell carcinoma: a comprehensive review","volume":"7","author":"Ravindran","year":"2025","journal-title":"J Liq Biopsy"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib105","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/jop.12721","article-title":"PAI-1, CAIX, and VEGFA expressions as prognosis markers in oral squamous cell carcinoma","volume":"47","author":"Peterle","year":"2018","journal-title":"J Oral Pathol Med"},{"issue":"8","key":"10.1016\/j.coms.2026.08.002_bib106","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1111\/odi.13747","article-title":"Tissue biomarkers for predicting the risk of oral cancer in patients diagnosed with oral leukoplakia: a systematic review","volume":"27","author":"Monteiro","year":"2021","journal-title":"Oral Dis"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib107","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12903-025-05898-3","article-title":"Role of circulating tumor DNA and cell-free DNA biomarkers in diagnosis and prognosis of oral cancer - a systematic review","volume":"25","author":"Mohammad","year":"2025","journal-title":"BMC Oral Health"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib108","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/jop.13608","article-title":"Prognostic value of Ki-67 in the invasive Zone of oral squamous cell carcinoma","volume":"54","author":"Li","year":"2025","journal-title":"J Oral Pathol Med"},{"issue":"Suppl 1","key":"10.1016\/j.coms.2026.08.002_bib109","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/s12105-012-0369-0","article-title":"p16 Immunohistochemistry as a standalone test for risk stratification in oropharyngeal squamous cell carcinoma","volume":"6","author":"Lewis","year":"2012","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.coms.2026.08.002_bib110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/jcar.JCar_17_18","article-title":"Molecular pathways of oral cancer that predict prognosis and survival: a systematic review","volume":"17","author":"Lakshminarayana","year":"2018","journal-title":"J Carcinog"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib111","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1200\/JCO.2007.13.4072","article-title":"Podoplanin: a novel marker for oral cancer risk in patients with oral premalignancy","volume":"26","author":"Kawaguchi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coms.2026.08.002_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149382","article-title":"miRNAs in oral cancer; diagnostic and prognostic roles","volume":"951","author":"Arabi","year":"2025","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib113","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/0022034518756330","article-title":"Calprotectin and the initiation and progression of head and neck cancer","volume":"97","author":"Argyris","year":"2018","journal-title":"J Dent Res"},{"key":"10.1016\/j.coms.2026.08.002_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oraloncology.2019.05.027","article-title":"Intracellular calprotectin (S100A8\/A9) controls epithelial differentiation and caspase-mediated cleavage of EGFR in head and neck squamous cell carcinoma","volume":"95","author":"Argyris","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.coms.2026.08.002_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.106304","article-title":"Intracellular calprotectin (S100A8\/A9) facilitates DNA damage responses and promotes apoptosis in head and neck squamous cell carcinoma","volume":"137","author":"Argyris","year":"2023","journal-title":"Oral Oncol"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069395","article-title":"S100A8\/A9 (calprotectin) negatively regulates G2\/M cell cycle progression and growth of squamous cell carcinoma","volume":"8","author":"Khammanivong","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib117","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41588-019-0558-9","article-title":"PCAWG Consortium. The landscape of viral associations in human cancers","volume":"52","author":"Zapatka","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/j.coms.2026.08.002_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105109","article-title":"Human papillomavirus genotype distribution in head and neck cancer: informing developing strategies for cancer prevention, diagnosis, treatment and surveillance","volume":"113","author":"Mashiana","year":"2021","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib119","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/annonc\/mdr006","article-title":"Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial","volume":"22","author":"Posner","year":"2011","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib121","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.coms.2018.06.001","article-title":"Epidemiology and demographics of the head and neck cancer population","volume":"30","author":"Cohen","year":"2018","journal-title":"Oral Maxillofac Surg Clin North Am"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib122","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib123","doi-asserted-by":"crossref","DOI":"10.3390\/v10020080","article-title":"The intersection of HPV epidemiology, genomics and mechanistic studies of HPV-mediated carcinogenesis","volume":"10","author":"Mirabello","year":"2018","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib124","doi-asserted-by":"crossref","DOI":"10.3390\/cancers8040041","article-title":"HPV positive head and neck cancers: molecular pathogenesis and evolving treatment strategies","volume":"8","author":"Dok","year":"2016","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10555-005-5045-3","article-title":"Human papillomavirus in head and neck cancer: molecular biology and clinicopathological correlations","volume":"24","author":"Szentirmay","year":"2005","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib126","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","article-title":"Human papillomavirus testing in Head and Neck Carcinomas: guideline from the college of American pathologists","volume":"142","author":"Lewis","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib127","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s12105-022-01467-0","article-title":"Human papillomavirus-associated oral cavity squamous cell carcinoma: an entity with distinct morphologic and clinical features","volume":"16","author":"Lewis","year":"2022","journal-title":"Head Neck Pathol"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/85330","article-title":"PD-L2 is a second ligand for PD-1 and inhibits T cell activation","volume":"2","author":"Latchman","year":"2001","journal-title":"Nat Immunol"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib129","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1158\/1535-7163.MCT-14-0983","article-title":"PD-L1 expression as a predictive biomarker in cancer immunotherapy","volume":"14","author":"Patel","year":"2015","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib130","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am J Cancer Res"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib131","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib132","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00262-004-0593-x","article-title":"Interaction of PD-L1 on tumor cells with PD-1 on tumor-specific T cells as a mechanism of immune evasion: implications for tumor immunotherapy","volume":"54","author":"Blank","year":"2005","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib133","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.coms.2026.08.002_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104722","article-title":"Prognostic and clinicopathological significance of PD-L1 overexpression in oral squamous cell carcinoma: a systematic review and comprehensive meta-analysis","volume":"106","author":"Lenouvel","year":"2020","journal-title":"Oral Oncol"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib135","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/his.14562","article-title":"Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study","volume":"80","author":"Cerbelli","year":"2022","journal-title":"Histopathology"},{"issue":"10212","key":"10.1016\/j.coms.2026.08.002_bib136","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","article-title":"Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study","volume":"394","author":"Burtness","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib137","doi-asserted-by":"crossref","DOI":"10.3390\/jpm15040126","article-title":"PD-L1\/PD-1 expression in the treatment of oral squamous cell carcinoma and oral potentially malignant disorders: an overview of reviews","volume":"15","author":"Al-Azzawi","year":"2025","journal-title":"J Pers Med"},{"key":"10.1016\/j.coms.2026.08.002_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102428","article-title":"Clinical trial data of Anti-PD-1\/PD-L1 therapy for recurrent or metastatic nasopharyngeal carcinoma: a review","volume":"109","author":"Adkins","year":"2022","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib139","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12537","article-title":"High PD-L1 expression in the tumour cells did not correlate with poor prognosis of patients suffering for oral squamous cells carcinoma: a meta-analysis of the literature","volume":"52","author":"Troiano","year":"2019","journal-title":"Cell Prolif"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071937","article-title":"Immune checkpoint inhibitors in oral cavity squamous cell carcinoma and oral potentially malignant disorders: a systematic review","volume":"12","author":"Kujan","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.coms.2026.08.002_bib141","first-page":"1222","article-title":"[Programmed death ligand 1 expression and CD8","volume":"50","author":"Gu","year":"2021","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib142","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.oooo.2023.07.046","article-title":"Intraoral salivary lymphoepithelial carcinoma: clinicopathologic and immunophenotypic characterization of 3 cases indicates elevated programmed death-ligand 1 expression","volume":"136","author":"Argyris","year":"2023","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.coms.2026.08.002_bib143","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102357","article-title":"Frequent PD-L1 expression in oral squamous cell carcinoma of non-smokers and non-drinkers, and association of tumor infiltrating lymphocytes with favorable prognosis","volume":"55","author":"Mulder","year":"2025","journal-title":"Transl Oncol"},{"key":"10.1016\/j.coms.2026.08.002_bib144","article-title":"Immunotherapy advances in locally advanced and recurrent\/metastatic head and neck squamous cell carcinoma and its relationship with human papillomavirus","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib145","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/odi.13509","article-title":"Clinicopathological and prognostic significance of PD-L1 in oral cancer: a preliminary retrospective immunohistochemistry study","volume":"27","author":"Lenouvel","year":"2021","journal-title":"Oral Dis"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib146","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41416-018-0131-9","article-title":"Efficacy and safety of pembrolizumab in recurrent\/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012","volume":"119","author":"Mehra","year":"2018","journal-title":"Br J Cancer"},{"issue":"19","key":"10.1016\/j.coms.2026.08.002_bib147","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib148","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1742-4658.2009.07448.x","article-title":"Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer","volume":"277","author":"Mitsudomi","year":"2010","journal-title":"FEBS J"},{"issue":"15","key":"10.1016\/j.coms.2026.08.002_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241511888","article-title":"Prognostic and clinicopathological significance of Epidermal Growth Factor Receptor (EGFR) expression in oral squamous cell carcinoma: systematic review and meta-analysis","volume":"24","author":"Civico-Ortega","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.4103\/0973-1482.191027","article-title":"Expression of p53, epidermal growth factor receptor, c-erbB2 in oral leukoplakias and oral squamous cell carcinomas","volume":"14","author":"Singla","year":"2018","journal-title":"J Cancer Res Therapeut"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib151","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/jomfp.jomfp_310_21","article-title":"Immunohistochemical study of epidermal growth factor receptor, human epidermal growth factor receptor 2\/neu, p53, and Ki67 in oral squamous cell carcinoma","volume":"26","author":"Mohanapure","year":"2022","journal-title":"J Oral Maxillofac Pathol"},{"issue":"9","key":"10.1016\/j.coms.2026.08.002_bib152","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1586\/era.10.115","article-title":"Molecular biology of squamous cell carcinoma of the head and neck: relevance and therapeutic implications","volume":"10","author":"Schmitz","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib153","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10555-005-5052-4","article-title":"Molecular therapy of head and neck cancer","volume":"24","author":"Modjtahedi","year":"2005","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib154","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1186\/s12903-025-05982-8","article-title":"Salivary EGF: EGFR ratio as potential early diagnostic biomarker for oral cancer detection in tobacco chewers: a preliminary cross-sectional study","volume":"25","author":"Kaul-Ghanekar","year":"2025","journal-title":"BMC Oral Health"},{"issue":"4\u20136","key":"10.1016\/j.coms.2026.08.002_bib155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000086970","article-title":"Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma","volume":"68","author":"Soni","year":"2005","journal-title":"Oncology"},{"key":"10.1016\/j.coms.2026.08.002_bib156","doi-asserted-by":"crossref","DOI":"10.1100\/2012\/978327","article-title":"Cyclin d1 expression and its correlation with histopathological differentiation in oral squamous cell carcinoma","volume":"2012","author":"Saawarn","year":"2012","journal-title":"Sci World J"},{"key":"10.1016\/j.coms.2026.08.002_bib157","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.archoralbio.2019.01.018","article-title":"Clinicopathological significance of tumor cyclin D1 expression in oral cancer","volume":"99","author":"Ramos-Garcia","year":"2019","journal-title":"Arch Oral Biol"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib158","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4103\/jomfp.JOMFP_164_20","article-title":"Cyclin D1 in oral premalignant lesions and oral squamous cell carcinoma: an immunohistochemical study","volume":"24","author":"Moharil","year":"2020","journal-title":"J Oral Maxillofac Pathol"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib159","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1034\/j.1600-0714.2000.290404.x","article-title":"Cyclin D1 expression in oral squamous cell carcinomas: clinicopathological relevance and correlation with p53 expression","volume":"29","author":"Lam","year":"2000","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib160","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1158\/0008-5472.CAN-03-2144","article-title":"Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck","volume":"64","author":"Ginos","year":"2004","journal-title":"Cancer Res"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib161","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/bjc.2017.244","article-title":"Prognostic biomarkers for oral tongue squamous cell carcinoma: a systematic review and meta-analysis","volume":"117","author":"Almangush","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.coms.2026.08.002_bib162","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1477-7819-10-40","article-title":"Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma","volume":"10","author":"Huang","year":"2012","journal-title":"World J Surg Oncol"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib163","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib164","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7150\/jca.14214","article-title":"What is the prognostic significance of Ki-67 positivity in oral squamous cell carcinoma?","volume":"7","author":"Xie","year":"2016","journal-title":"J Cancer"},{"issue":"Suppl 1","key":"10.1016\/j.coms.2026.08.002_bib165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1046\/j.1365-2184.35.s1.12.x","article-title":"Epithelial cell proliferative activity and oral cancer progression","volume":"35 Suppl 1","author":"Thomson","year":"2002","journal-title":"Cell Prolif"},{"issue":"11","key":"10.1016\/j.coms.2026.08.002_bib166","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.31557\/APJCP.2018.19.11.3279","article-title":"Ki-67 prognostic value in different histological grades of oral epithelial dysplasia and oral squamous cell carcinoma","volume":"19","author":"Takkem","year":"2018","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.coms.2026.08.002_bib167","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1590\/1807-3107bor-2017.vol31.0066","article-title":"Ki-67 protein predicts survival in oral squamous carcinoma cells: an immunohistochemical study","volume":"31","author":"Lopes","year":"2017","journal-title":"Braz Oral Res"},{"issue":"40","key":"10.1016\/j.coms.2026.08.002_bib168","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017472","article-title":"Associations between FDG-PET and Ki 67-index in head and neck cancer: a meta-analysis","volume":"98","author":"Meyer","year":"2019","journal-title":"Medicine (Baltim)"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib169","doi-asserted-by":"crossref","DOI":"10.3892\/or.2023.8650","article-title":"Emerging histological and serological biomarkers in oral squamous cell carcinoma: applications in diagnosis, prognosis evaluation and personalized therapeutics","volume":"50","author":"Pekarek","year":"2023","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ijos.2016.38","article-title":"Saliva in the diagnosis of diseases","volume":"8","author":"Zhang","year":"2016","journal-title":"Int J Oral Sci"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib171","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40496-014-0014-y","article-title":"Salivary biomarkers for detection of oral squamous cell carcinoma - current state and recent advances","volume":"1","author":"Yakob","year":"2014","journal-title":"Curr Oral Health Rep"},{"key":"10.1016\/j.coms.2026.08.002_bib172","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/8761860","article-title":"A new approach for the diagnosis of systemic and oral diseases based on salivary biomolecules","volume":"2019","author":"Roi","year":"2019","journal-title":"Dis Markers"},{"issue":"17","key":"10.1016\/j.coms.2026.08.002_bib173","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-09-0736","article-title":"Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection","volume":"15","author":"Park","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib174","doi-asserted-by":"crossref","first-page":"301","DOI":"10.5125\/jkaoms.2020.46.5.301","article-title":"Salivary biomarkers in oral squamous cell carcinoma","volume":"46","author":"Nguyen","year":"2020","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1601-0825.2009.01646.x","article-title":"Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer","volume":"16","author":"Liu","year":"2010","journal-title":"Oral Dis"},{"issue":"24","key":"10.1016\/j.coms.2026.08.002_bib176","doi-asserted-by":"crossref","first-page":"8442","DOI":"10.1158\/1078-0432.CCR-04-1167","article-title":"Salivary transcriptome diagnostics for oral cancer detection","volume":"10","author":"Li","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib177","article-title":"Malignancies and biosensors: a focus on oral cancer detection through salivary biomarkers","volume":"11","author":"Goldoni","year":"2021","journal-title":"Biosensors (Basel)"},{"issue":"13","key":"10.1016\/j.coms.2026.08.002_bib178","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1158\/1078-0432.CCR-15-1761","article-title":"Salivary biomarkers for detection of oral squamous cell carcinoma in a Taiwanese population","volume":"22","author":"Gleber-Netto","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib179","article-title":"Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions","volume":"7","author":"Walsh","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib180","article-title":"Salivary IL-8, IL-6 and TNF-alpha as potential diagnostic biomarkers for oral cancer","volume":"7","author":"Sahibzada","year":"2017","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.coms.2026.08.002_bib181","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jdsr.2023.10.003","article-title":"Salivary biomarkers for early detection of oral squamous cell carcinoma (OSCC) and head\/neck squamous cell carcinoma (HNSCC): a systematic review and network meta-analysis","volume":"60","author":"Khijmatgar","year":"2024","journal-title":"Jpn Dent Sci Rev"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib182","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/odi.12216","article-title":"Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma","volume":"21","author":"Rajkumar","year":"2015","journal-title":"Oral Dis"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib183","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216561","article-title":"Diagnostic accuracy and prognostic applications of CYFRA 21-1 in head and neck cancer: a systematic review and meta-analysis","volume":"14","author":"Liu","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib184","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jop.12726","article-title":"Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis","volume":"47","author":"Mello","year":"2018","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s12105-019-01020-6","article-title":"Oral epithelial dysplasia and premalignancy","volume":"13","author":"Woo","year":"2019","journal-title":"Head Neck Pathol"},{"issue":"11","key":"10.1016\/j.coms.2026.08.002_bib186","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.adaj.2017.08.045","article-title":"Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association","volume":"148","author":"Lingen","year":"2017","journal-title":"J Am Dent Assoc"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib187","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.adaj.2017.07.032","article-title":"Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: a report of the American Dental Association","volume":"148","author":"Lingen","year":"2017","journal-title":"J Am Dent Assoc"},{"issue":"12","key":"10.1016\/j.coms.2026.08.002_bib188","article-title":"Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults","volume":"12","author":"Walsh","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"10.1016\/j.coms.2026.08.002_bib189","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/1097-0142(20011101)92:9<2349::AID-CNCR1582>3.0.CO;2-I","article-title":"Accumulative increase of loss of heterozygosity from leukoplakia to foci of early cancerization in leukoplakia of the oral cavity","volume":"92","author":"Jiang","year":"2001","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib190","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm0696-682","article-title":"Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment","volume":"2","author":"Mao","year":"1996","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib191","first-page":"2718","article-title":"Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment","volume":"6","author":"Partridge","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib192","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1600-0714.1995.tb01166.x","article-title":"Observer variability in the histologic assessment of oral premalignant lesions","volume":"24","author":"Karabulut","year":"1995","journal-title":"J Oral Pathol Med"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib193","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.oooo.2012.10.015","article-title":"The binary oral dysplasia grading system: validity testing and suggested improvement","volume":"115","author":"Nankivell","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib194","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.oooo.2013.09.017","article-title":"Malignant transformation of oral epithelial dysplasia: a real-world evaluation of histopathologic grading","volume":"117","author":"Dost","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib195","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4103\/0973-029X.185928","article-title":"Inter- and intra-observer variability in three grading systems for oral epithelial dysplasia","volume":"20","author":"Krishnan","year":"2016","journal-title":"J Oral Maxillofac Pathol"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib196","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0714.2007.00584.x","article-title":"Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement","volume":"37","author":"Warnakulasuriya","year":"2008","journal-title":"J Oral Pathol Med"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib197","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.oraloncology.2006.03.009","article-title":"Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: an attempt to understand the sources of variation","volume":"43","author":"Kujan","year":"2007","journal-title":"Oral Oncol"},{"issue":"9","key":"10.1016\/j.coms.2026.08.002_bib198","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/jop.13056","article-title":"Intra-observer and inter-observer variability in two grading systems for oral epithelial dysplasia: a multi-centre study in India","volume":"49","author":"Ranganathan","year":"2020","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib199","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0714.2004.0037n.x","article-title":"Interobserver reliability in the histopathologic diagnosis of oral pre-malignant and malignant lesions","volume":"33","author":"Fischer","year":"2004","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib200","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S1079-2104(05)80201-X","article-title":"Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia","volume":"80","author":"Abbey","year":"1995","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib201","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0030-4220(72)90468-9","article-title":"Observations on the clinical characteristics of oral lesions showing histologic epithelial dysplasia","volume":"33","author":"Mincer","year":"1972","journal-title":"Oral Surg Oral Med Oral Pathol"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib202","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1600-0714.2009.00782.x","article-title":"Outcome of oral dysplasia: a retrospective hospital-based study of 207 patients with a long follow-up","volume":"38","author":"Arduino","year":"2009","journal-title":"J Oral Pathol Med"},{"issue":"12","key":"10.1016\/j.coms.2026.08.002_bib203","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/hed.21131","article-title":"Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis","volume":"31","author":"Mehanna","year":"2009","journal-title":"Head Neck"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib204","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/jnci\/djz238","article-title":"Oral leukoplakia and risk of progression to oral cancer: a population-based cohort study","volume":"112","author":"Chaturvedi","year":"2020","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"10.1016\/j.coms.2026.08.002_bib205","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1158\/1940-6207.CAPR-12-0173","article-title":"Loss of heterozygosity (LOH) profiles--validated risk predictors for progression to oral cancer","volume":"5","author":"Zhang","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib206","first-page":"1860","article-title":"Profiling clonality and progression in multiple premalignant and malignant oral lesions identifies a subgroup of cases with a distinct presentation of squamous cell carcinoma","volume":"7","author":"Partridge","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib207","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1067\/moe.2003.97","article-title":"Increased allelic loss in toluidine blue-positive oral premalignant lesions","volume":"95","author":"Epstein","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"issue":"1","key":"10.1016\/j.coms.2026.08.002_bib208","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/gcc.10294","article-title":"Novel regions of amplification on 8q distinct from the MYC locus and frequently altered in oral dysplasia and cancer","volume":"39","author":"Garnis","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.coms.2026.08.002_bib209","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1476-4598-8-50","article-title":"Genomic imbalances in precancerous tissues signal oral cancer risk","volume":"8","author":"Garnis","year":"2009","journal-title":"Mol Cancer"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib210","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/ijc.10748","article-title":"Progression of microsatellite instability from premalignant lesions to tumors of the head and neck","volume":"102","author":"Ha","year":"2002","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib211","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s100380170069","article-title":"Frequent loss of heterozygosity at 3p25-p26 is associated with invasive oral squamous cell carcinoma","volume":"46","author":"Kayahara","year":"2001","journal-title":"J Hum Genet"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib212","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1368-8375(97)00052-3","article-title":"Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer","volume":"34","author":"Partridge","year":"1998","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib213","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S1368-8375(97)00035-3","article-title":"Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions","volume":"33","author":"Partridge","year":"1997","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib214","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/labinvest.3780271","article-title":"A high frequency of allelic loss in oral verrucous lesions may explain malignant risk","volume":"81","author":"Poh","year":"2001","journal-title":"Lab Invest"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib215","first-page":"357","article-title":"Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia","volume":"6","author":"Rosin","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"23","key":"10.1016\/j.coms.2026.08.002_bib216","first-page":"5258","article-title":"The use of exfoliative cell samples to map clonal genetic alterations in the oral epithelium of high-risk patients","volume":"57","author":"Rosin","year":"1997","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.coms.2026.08.002_bib217","first-page":"6447","article-title":"3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites","volume":"62","author":"Rosin","year":"2002","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.coms.2026.08.002_bib218","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1158\/1078-0432.CCR-03-0632","article-title":"Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study","volume":"10","author":"Tabor","year":"2004","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib219","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1158\/1940-6207.CAPR-08-0123","article-title":"Multiple aberrations of chromosome 3p detected in oral premalignant lesions","volume":"1","author":"Tsui","year":"2008","journal-title":"Cancer Prev Res (Phila)"},{"issue":"11","key":"10.1016\/j.coms.2026.08.002_bib220","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/1097-0142(20010601)91:11<2148::AID-CNCR1243>3.0.CO;2-G","article-title":"Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management","volume":"91","author":"Zhang","year":"2001","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.coms.2026.08.002_bib221","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1034\/j.1600-0714.2001.300901.x","article-title":"Loss of heterozygosity: a potential tool in management of oral premalignant lesions?","volume":"30","author":"Zhang","year":"2001","journal-title":"J Oral Pathol Med"},{"issue":"12","key":"10.1016\/j.coms.2026.08.002_bib222","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/labinvest.3700342","article-title":"A noninvasive genetic screening test to detect oral preneoplastic lesions","volume":"85","author":"Bremmer","year":"2005","journal-title":"Lab Invest"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib223","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1600-0714.2008.00682.x","article-title":"Comparative evaluation of genetic assays to identify oral pre-cancerous fields","volume":"37","author":"Bremmer","year":"2008","journal-title":"J Oral Pathol Med"},{"issue":"2","key":"10.1016\/j.coms.2026.08.002_bib224","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00405-007-0420-z","article-title":"The role of chromosomal aberrations in premalignant and malignant lesions in head and neck squamous cell carcinoma","volume":"265","author":"Abou-Elhamd","year":"2008","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"7283","key":"10.1016\/j.coms.2026.08.002_bib225","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib226","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.oraloncology.2008.07.006","article-title":"DNA ploidy analysis by image cytometry helps to identify oral epithelial dysplasias with a high risk of malignant progression","volume":"45","author":"Torres-Rendon","year":"2009","journal-title":"Oral Oncol"},{"issue":"4","key":"10.1016\/j.coms.2026.08.002_bib227","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.oraloncology.2004.10.009","article-title":"Heterogeneity, histological features and DNA ploidy in oral carcinoma by image-based analysis","volume":"41","author":"Diwakar","year":"2005","journal-title":"Oral Oncol"},{"issue":"5\u20136","key":"10.1016\/j.coms.2026.08.002_bib228","first-page":"373","article-title":"Oral cancer genesis and progression: DNA near-diploid aneuploidization and endoreduplication by high resolution flow cytometry","volume":"32","author":"Donadini","year":"2010","journal-title":"Cell Oncol"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib229","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.oraloncology.2009.03.008","article-title":"DNA aneuploidy and dysplasia in oral potentially malignant disorders: association with cigarette smoking and site","volume":"45","author":"Pentenero","year":"2009","journal-title":"Oral Oncol"},{"issue":"1 Pt 1","key":"10.1016\/j.coms.2026.08.002_bib230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0901-5027(05)80855-0","article-title":"Flow cytometric analysis of nuclear DNA content in oral leukoplakia: relation to clinicopathologic findings","volume":"24","author":"Saito","year":"1995","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"9","key":"10.1016\/j.coms.2026.08.002_bib231","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/sj.bjc.6605905","article-title":"Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma","volume":"103","author":"Bradley","year":"2010","journal-title":"Br J Cancer"},{"issue":"10","key":"10.1016\/j.coms.2026.08.002_bib232","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.oraloncology.2011.07.025","article-title":"Prognostic value of DNA ploidy status in patients with oral leukoplakia","volume":"47","author":"Bremmer","year":"2011","journal-title":"Oral Oncol"},{"issue":"8","key":"10.1016\/j.coms.2026.08.002_bib233","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/1940-6207.CAPR-13-0001","article-title":"Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders","volume":"6","author":"Sperandio","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"issue":"12","key":"10.1016\/j.coms.2026.08.002_bib234","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.oraloncology.2013.09.006","article-title":"Chromosome instability predicts the progression of premalignant oral lesions","volume":"49","author":"Siebers","year":"2013","journal-title":"Oral Oncol"},{"issue":"5","key":"10.1016\/j.coms.2026.08.002_bib235","first-page":"415","article-title":"Prognostic biomarkers for malignant progression of oral epithelial dysplasia: an updated systematic review and meta-analysis","volume":"62","author":"Turton","year":"2024","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"7","key":"10.1016\/j.coms.2026.08.002_bib236","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100153","article-title":"Abnormal p53 immunohistochemical patterns shed light on the aggressiveness of oral epithelial dysplasia","volume":"36","author":"Novack","year":"2023","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib237","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/ijc.28473","article-title":"S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia","volume":"134","author":"Kaur","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.coms.2026.08.002_bib238","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/978-1-4939-9030-6_48","article-title":"S100 proteins as biomarkers in risk estimations for malignant transformation in oral lesions","volume":"1929","author":"Probstmeier","year":"2019","journal-title":"Methods Mol Biol"},{"issue":"3","key":"10.1016\/j.coms.2026.08.002_bib239","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.oooo.2016.11.004","article-title":"Individualized five-year risk assessment for oral premalignant lesion progression to cancer","volume":"123","author":"Hwang","year":"2017","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"6","key":"10.1016\/j.coms.2026.08.002_bib240","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/PAI.0000000000001132","article-title":"Assessing oral epithelial dysplasia risk for transformation to cancer: Comparison between histologic grading systems versus S100A7 immunohistochemical signature-based grading","volume":"31","author":"Darling","year":"2023","journal-title":"Appl Immunohistochem Mol Morphol"}],"container-title":["Oral and Maxillofacial Surgery Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369926000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1042369926000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:08:48Z","timestamp":1790323728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1042369926000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":240,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1042369926000531"],"URL":"https:\/\/doi.org\/10.1016\/j.coms.2026.08.002","relation":{},"ISSN":["1042-3699"],"issn-type":[{"value":"1042-3699","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological and Molecular Biomarkers in Oral Potentially Malignant Disorders and Oral Cavity Squamous Cell Carcinoma\u2014Innovation and Insights","name":"articletitle","label":"Article Title"},{"value":"Oral and Maxillofacial Surgery Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coms.2026.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}